Sato Pharmaceutical recalls INON ACE antacid tablets because they break down too slowly
The tablets failed a test of how fast they break down, taking longer than expected to disintegrate.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
- Company
- Sato Pharmaceutical Co., Ltd
- Hazard
- Failed Disintegration Specifications: above the time expected.
- Units
- 3,640 bottles
- Where sold
- CA and HI
- FDA classification
- Class II · Ongoing
- Classified by FDA
- January 27, 2026
- Recall started
- December 19, 2025
- FDA enforcement report
- February 4, 2026
- Identifiers
- Codes: Lot#: PWXT, Exp 1/31/2027
- FDA recall number: D-0298-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
- Reason for recall
- Failed Disintegration Specifications: above the time expected.
- Classification
- Class II (Ongoing)
- Distribution
- CA and HI
- Quantity
- 3,640 bottles
Related recalls
Sato Pharmaceutical recalls Yunker Energy & Health Herbal Supplement because it lacks the labeled amount of Vitamin E
The recalled Yunker Energy & Health Herbal Supplement with Vitamins, sold in 30ml single, 3-pack and 10-pack sizes, does not meet its label claim for Vitamin E.
Sato Pharmaceutical Inc. · 25,130 units across all package sizes
Greenwich Rx recalls Glutathione Injection 10 mL vials over microbial contamination
The notice says the sterile Glutathione Injection (200 mg/mL, 10 mL multi-dose vial, Subcutaneous Only) has microbial contamination, and 4,319 vials were sent across the US.
Greenwich Rx · 4,319 vials
Pritam International recalls Brush Buddies and evo toothpastes over manufacturing practice problems
The notice says these anticavity fluoride toothpastes were made with deviations from current good manufacturing practices and were distributed across the US.
Pritam International Private Limited · 3,309,696 units
Strides Pharma recalls Cinacalcet Tablets 30 mg because they failed dissolution specifications
The 30 mg Cinacalcet Tablets in 30-count bottles failed dissolution specifications, and 49,488 bottles were distributed across the US.
Strides Pharma INC · 49,488 30-count bottles
Viatris recalls telmisartan and amlodipine tablets because telmisartan content may be too high
The tablets may contain more telmisartan than they are supposed to, so the content in these lots could go over the limit set for the product.
Viatris, Inc. · 21,620 30-count bottles
Pfizer recalls Levoxyl 175 mcg levothyroxine sodium tablets over weaker-than-labeled strength
The tablets are subpotent, meaning they are weaker than labeled, after a stability test confirmed an out-of-specification assay result.
Pfizer · 15,949 units